🇺🇸 FDA
Pipeline program

Opioid-Related Disorders

NIDA-11160-5

Phase 2 small_molecule terminated

Quick answer

Opioid-Related Disorders for Heroin Dependence is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 3 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Heroin Dependence
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials